Literature DB >> 7393824

Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis.

R S Stern, I M Marks, J Wright, D K Luscombe.   

Abstract

The relationship between plasma levels of clomipramine and desmethylclomipramine and clinical response was studied in a group of patients with obsessive-compulsive neurosis. In general the response was best in the middle range of plasma concentrations, showing the inverted U curve well recognized with nortriptyline. However, the results of this study suggest that the response of compulsive rituals correlates with levels of plasma clomipramine, while depression appears to correlate with plasma levels of desmethylclomipramine. The former relationship may be the stronger. There may also be some relationship between side effects and relative plasma levels of clomipramine and desmethylclomipramine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7393824

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

Review 1.  Measurement of serum drug levels in the assessment of antidepressants.

Authors:  S A Montgomery
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

Review 2.  Current antidepressant drugs: their clinical use.

Authors:  L E Hollister
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

Review 3.  Pharmacokinetic optimisation of therapy with newer antidepressants.

Authors:  P J Goodnick
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

4.  Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder.

Authors:  Bruno Aouizerate; Dominique Guehl; Emmanuel Cuny; Alain Rougier; Pierre Burbaud; Jean Tignol; Bernard Bioulac
Journal:  Neuropsychiatr Dis Treat       Date:  2005-09       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.